Autophagy in idiopathic pulmonary fibrosis.
Patel AS, Lin L, Geyer A, Haspel JA, An CH, Cao J, Rosas IO, Morse D. · 2012
Read Autophagy in idiopathic pulmonary fibrosis. by Patel AS, Lin L, Geyer A, Haspel JA, An CH, Cao J, Rosas IO, Morse D. (2012) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc3399849.txt.
Introduction
Patel and colleagues investigated in 2012 whether a cell's self-cleaning system falters in idiopathic pulmonary fibrosis, a scarring lung disease with no clear cause. The system, called autophagy, recycles worn parts and helps cells survive stress. The team examined lung tissue from patients and tested lung fibroblasts and a mouse model of lung scarring.
Patient tissue showed weak autophagy on several measures, with fewer of the recycling sacs visible under the microscope. A scarring signal, TGF-beta, shut the process down in fibroblasts, partly through a growth switch. A drug that restarts cleaning reduced scarring in mice, while blocking key cleaning genes did the opposite. Failed cleaning, they suggest, helps drive the fibrosis.
Catalog record
| CREATOR | Patel AS, Lin L, Geyer A, Haspel JA, An CH, Cao J, Rosas IO, Morse D. |
|---|---|
| YEAR | 2012 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 44 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Autophagy in Idiopathic Pulmonary Fibrosis By Avignat S. Patel, Ling Lin, Alexander Geyer, Jeffrey A. Haspel, Chang Hyeok An, Jiaofei Cao, Ivan O. Rosas, Danielle Morse, Oliver Eickelberg Published in: PLoS ONE DOI: 10.1371/journal.pone.0041394 ABSTRACT Background Autophagy is a basic cellular homeostatic process important to cell fate decisions under conditions of stress. Dysregulation of autophagy impacts numerous human diseases including cancer and chronic obstructive lung disease. This study investigates the role of autophagy in idiopathic pulmonary fibrosis. Methods Human lung tissues from patients with IPF were analyzed for autophagy markers and modulating proteins using western blotting, confocal microscopy and transmission electron microscopy. To study the effects of TGF-β1 on autophagy, human lung fibroblasts were monitored by fluorescence microscopy and western blotting. In vivo experiments were done using the bleomycin-induced fibrosis mouse model. Results Lung tissues from IPF patients demonstrate evidence of decreased autophagic activity as assessed by LC3, p62 protein expression and immunofluorescence, and numbers of autophagosomes. TGF-β1 inhibits autophagy in fibroblasts in vitro at least in part via activation of mTORC1; expression of TIGAR is also increased in response to TGF-β1. In the bleomycin model of pulmonary fibrosis, rapamycin treatment is antifibrotic, and rapamycin also decreases expression of á-smooth muscle actin and fibronectin by fibroblasts in vitro. Inhibition of key regulators of autophagy, LC3 and beclin-1, leads to the opposite effect on fibroblast expression of á-smooth muscle actin and fibronectin. Conclusion Autophagy is not induced in pulmonary fibrosis despite activation of pathways known to promote autophagy. Impairment of autophagy by TGF-β1 may represent a mechanism for the promotion of fibrogenesis in IPF. INTRODUCTION Autophagy is a catabolic process by which components of the cytoplasm are degraded in lysosomes. During this process, cytoplasmic cargo is sequestered within double-membraned autophagosomes and then degraded after fusion of autophagosomes with lysosomes. Although this morphological process was originally described half a century ago [1], the molecular mechanisms of autophagy have been only lately described, leading to recent interest in the role of autophagy in disease. Autophagy was first understood as a process by which organelles and macromolecules could be catabolized to remove damaged structures or to provide energy under conditions of nutrient starvation. The importance of autophagy to homeostasis and development has been underscored by numerous studies in yeast and mice [2], [3], [4], [5]. The function of autophagy in human disease and pre-clinical models of disease appears to be highly pleiotropic, however, and it is not always possible to predict the outcome of interventions that affect autophagy. In some instances, autophagy has been shown to be an adaptive pro-survival response, whereas under other circumstances autophagy appears to promote cell death and morbidity [6], [7]. Relatively few studies have addressed the role of autophagy in the lung; hence the role of autophagy in adult lung disease remains largely undefined. Autophagy in chronic obstructive lung disease (COPD) is greatly enhanced in the epithelium and appears to precede apoptosis and contribute to progression of disease [8], [9]. In alveolar macrophages of COPD patients, however, there is an impairment in autophagy [10]. In cystic fibrosis, there is evidence that mutant CFTR protein impairs autophagosome formation via depletion of beclin-1 [11]. Recently, it was demonstrated that tumorigenesis in tuberous sclerosis complex (TSC) which includes pulmonary lymphangioleiomyomatosis (LAM) is autophagy dependent [12], and Mi et.al. found that IL-17 antagonism induces autophagy and is protective in a mouse model of fibrosis [13]. Whether autophagy influences the outcome of idiopathic pulmonary fibrosis (IPF), a disease involving multiple cell types and pathogenic mechanisms, is unknown. Recent advances in our understanding of the pathogenesis of IPF have underscored potential links with autophagy. Markers of ER stress have been shown to be increased in type II alveolar epithelial cells of IPF lungs compared with COPD or donor control lungs [14], and increased levels of ER stress promote fibrosis in experimental models [15]. ER stress is also known to induce autophagy [16], promoting cell survival [17] or death [18] in a context-specific manner. Markers of oxidative stress have also been identified in the lungs of IPF patients [19], and recent studies indicate that oxidative stress or elevated reactive oxygen species activate autophagy [20], [21]. Autophagy is also sensitive to oxygen tension and the hypoxia-inducible factor (HIF)-1α has been implicated as a major regulator of autophagy under hypoxic conditions [22]. Levels of HIF-1α are elevated in pulmonary fibrosis [23] and may contribute to disease progression [24], [25]. These associations suggest that autophagy is likely to be induced in pulmonary fibrosis. In this study, we used human tissues, the murine bleomycin model and an in vitro transforming growth factor-β1 (TGF-β1) model to explore the relationship of autophagy to fibrosis. RESULTS Autophagy is not increased in IPF An immunoblot for X-box binding protein 1 (XBP1), a pivotal gene in the endoplasmic reticulum (ER) stress response, is shown in figure 1A. This immunoblot confirms previously published findings that ER stress is elevated in IPF lungs relative to control lungs [14], which would be expected to lead to increased levels of autophagy [16], [17]. Similarly, levels of phosphorylated AMPK (pAMPK) are higher in IPF lung than control lungs (figure 1A). AMPK activation is a well known trigger of autophagy [26] and is phosphorylated in situations where ATP synthesis is decreased (hypoxia, ischemia, low nutrient availability) or ATP consumption is increased. Despite evidence of ER stress and AMPK activation, we show in figure 1B and 1C that LC3-II levels are significantly lower in whole tissue homogenate of lungs from patients with IPF compared with control lungs from transplant donors without IPF. LC3, otherwise known as “microtubule-associated protein 1 light chain 3”, or MAP1LC3, is commonly used to monitor autophagy in cultured cells and animal tissue. The cytosolic form of LC3 (termed LC3-I) is seen as the upper band in the immunoblot, and the autophagosomal membrane lipidated form (termed LC3-II) makes up the lower band [27]. We also show in figure 1D that p62 protein levels are higher in IPF than in control lung tissue. Levels of p62 (a chaperone molecule that carries cargo to the autophagosome for selective degradation) inversely correlate with autophagic activity [28]. We also assessed p62 levels by immunofluorescence confocal microscopy (Fig. 1E) and found higher amounts of p62 in IPF tissue than control, confirming the Western blot findings. Electron microscopy (EM), the gold standard for identification of autophagosomes, supports the Western blot and immunofluorescence results. In contrast to lungs of patients with COPD, which have previously been shown to exhibit elevated levels of autophagy [8], lungs from patients with IPF demonstrate only rare autophagosomes. This is shown in figure 1F panel D, where numerous autophagosomes in lung from a patient with COPD are labeled with white arrows; in contrast, few or no autophagosomes are seen in IPF (panel A, B) and control (Panel C) samples. Quantitation of autophagosome numbers is shown in figure 1G. Taken together, these data indicate that autophagy is not induced in lungs of patients with IPF despite activation of pathways known to increase levels of tissue autophagy. [Figure: Autophagy is not increased in IPF.A) IPF whole lung homogenate demonstrates increased ER stress (elevated XBP1 expression) and increased phosphorylation of AMPK, factors which should drive autophagy. B) LC3-II (lower band) expression in IPF whole